In a longitudinal cohort study with ten G551D CF patients, results from inflammatory mediators in nasal lavages indicated that the levels of IL-1β and IL-6 declined during 12 weeks after initiation of ivacaftor treatment, whereas IL-8 levels were decreased only up to 8 weeks of treatment [69]. Here, CXCL8 is linked to cystic fibrosis.